{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:02:32Z","timestamp":1789246952454,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00535-017-1425-z","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T12:57:28Z","timestamp":1515502648000},"page":"819-826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":160,"title":["Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis"],"prefix":"10.1007","volume":"53","author":[{"given":"Ken","family":"Shirabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Bekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolgormaa","family":"Gantumur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Narimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"1425_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad AA, Lopez AD, Shahraz S, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12:145. https:\/\/doi.org\/10.1186\/s12916-014-0145-y (PMID 25242656).","journal-title":"BMC Med"},{"key":"1425_CR2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdahal NH. Liver cirrhosis. Lancet. 2008;371:838\u201351.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1425_CR3","first-page":"S38","volume":"38","author":"JF Perz","year":"2003","unstructured":"Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2003;38(Suppl 1):S38\u201353.","journal-title":"J Hepatol"},{"key":"1425_CR4","doi-asserted-by":"crossref","first-page":"9880","DOI":"10.3748\/wjg.v22.i45.9880","volume":"22","author":"RN Karanjia","year":"2016","unstructured":"Karanjia RN, Crossey MM, Cox IJ, et al. Hepatic steatosis and fibrosis: non-invasive assessment. World J Gastroenterol. 2016;22:9880\u201397.","journal-title":"World J Gastroenterol"},{"key":"1425_CR5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40265-015-0401-2","volume":"75","author":"A Majumdar","year":"2015","unstructured":"Majumdar A, Kitson MT, Roberts SK. Treatment of hepatitis C in patients with cirrhosis: remaining challenges for direct-acting antiviral therapy. Drugs. 2015;75:823\u201334.","journal-title":"Drugs"},{"key":"1425_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/hep.20073","volume":"39","author":"C Camm\u00e0","year":"2004","unstructured":"Camm\u00e0 C, Di Bona D, Schepis F, et al. Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. Hepatology. 2004;39:333\u201342.","journal-title":"Hepatology"},{"issue":"3","key":"1425_CR7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, et al. American Association for the study of liver diseases. Liver biopsy. Hepatology. 2009;49(3):1017\u201344.","journal-title":"Hepatology"},{"key":"1425_CR8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47:598\u2013607.","journal-title":"J Hepatol"},{"key":"1425_CR9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1309\/W3XCNT4HKFBN2G0B","volume":"125","author":"E Cholongitas","year":"2006","unstructured":"Cholongitas E, Senzolo M, Standish R, et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol. 2006;125:710\u201321.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"1425_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(03)00191-0","volume":"39","author":"G Colloredo","year":"2003","unstructured":"Colloredo G, Guido M, Sonzogni A, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003;39(2):239\u201344.","journal-title":"J Hepatol"},{"key":"1425_CR11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","volume":"51","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao G, Friedman S, Iredale J. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445\u20139.","journal-title":"Hepatology"},{"issue":"1","key":"1425_CR12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-0031-1272836","volume":"31","author":"G Germani","year":"2011","unstructured":"Germani G, Hytiroglou P, Fotiadu A, et al. Assessment of fibrosis and cirrhosis in liver biopsies: an update. Semin Liver Dis. 2011;31(1):82\u201390.","journal-title":"Semin Liver Dis"},{"key":"1425_CR13","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.3748\/wjg.v21.i41.11567","volume":"21","author":"Y Lurie","year":"2015","unstructured":"Lurie Y, Webb M, Cytter-Kuint R, et al. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol. 2015;21:11567\u201383.","journal-title":"World J Gastroenterol"},{"key":"1425_CR14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00535-010-0365-7","volume":"46","author":"T Toshima","year":"2011","unstructured":"Toshima T, Shirabe K, Takeishi K, et al. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J Gastroenterol. 2011;46:705\u201311.","journal-title":"J Gastroenterol"},{"issue":"12","key":"1425_CR15","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705\u201313.","journal-title":"Ultrasound Med Biol"},{"key":"1425_CR16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.28337","volume":"63","author":"J Cui","year":"2016","unstructured":"Cui J, Heba E, Hernandez C, et al. Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: a prospective study. Hepatology. 2016;63:453\u201361.","journal-title":"Hepatology"},{"issue":"41","key":"1425_CR17","doi-asserted-by":"crossref","first-page":"11542","DOI":"10.3748\/wjg.v21.i41.11542","volume":"21","author":"R \u015eirli","year":"2015","unstructured":"\u015eirli R, Sporea I, Popescu A, et al. Ultrasound-based elastography for the diagnosis of portal hypertension in cirrhotics. World J Gastroenterol. 2015;21(41):11542\u201351.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1425_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000122602","volume":"51","author":"C Tatsumi","year":"2008","unstructured":"Tatsumi C, Kudo M, Ueshima K, et al. Noninvasive evaluation of hepatic fibrosis using serum fibrotic marker, transient elastography (FibroScan) and real-time tissue elastography. Intervirology. 2008;51(1):27\u201333.","journal-title":"Intervirology"},{"key":"1425_CR19","first-page":"518","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518\u201326.","journal-title":"Hepatology"},{"key":"1425_CR20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32\u20136.","journal-title":"Hepatology"},{"key":"1425_CR21","doi-asserted-by":"crossref","first-page":"18731","DOI":"10.1016\/S0021-9258(18)55124-3","volume":"266","author":"I Rosenberg","year":"1991","unstructured":"Rosenberg I, Cherayil BJ, Isselbacher KJ, et al. Mac-2-binding glycoproteins. Putative ligands for a cytosolic \u03b2-galactoside lectin. J Biol Chem. 1991;266:18731\u20136.","journal-title":"J Biol Chem"},{"key":"1425_CR22","doi-asserted-by":"crossref","first-page":"15690","DOI":"10.1074\/jbc.M200386200","volume":"277","author":"S Hellstern","year":"2002","unstructured":"Hellstern S, Sasaki T, Fauser C, et al. Functional studies on recombinant domains Mac-2-binding protein. J Biol Chem. 2002;277:15690\u20136.","journal-title":"J Biol Chem"},{"key":"1425_CR23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/emboj\/17.6.1606","volume":"17","author":"T Sasaki","year":"1998","unstructured":"Sasaki T, Brakebusch C, Engel J, et al. Mac-2 binging protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta 1 integrins, collagens and fibronectin. EMBO J. 1998;17:1606\u201313.","journal-title":"EMBO J"},{"key":"1425_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13706","author":"Y Bekki","year":"2016","unstructured":"Bekki Y, Yoshizumi T, Shimoda S, et al. Hepatic stellate cells secrete WFA+-M2BP. Its role in biological interactions with Kupffer cells. J Gastroenterol Hepatol. 2016. https:\/\/doi.org\/10.1111\/jgh.13706 (Epub ahead of print).","journal-title":"J Gastroenterol Hepatol"},{"key":"1425_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jpm.a.36107","author":"A Kianoush","year":"2017","unstructured":"Kianoush A, Nematollahi M, Waterfield JD, et al. Regulation of RAW 264.7 macrophage polarization on smooth and rough surface topographies by galectin-3. J Biomed Mater Res A. 2017. https:\/\/doi.org\/10.1002\/jpm.a.36107 (epubahead of print).","journal-title":"J Biomed Mater Res A"},{"key":"1425_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biopha.2016.01.014","volume":"78","author":"L Wang","year":"2016","unstructured":"Wang L, Guo XL. Molecular regulation of galectin 3 expression and therapeutic implication in cancer progression. Biomed Pharmacother. 2016;78:165\u201371.","journal-title":"Biomed Pharmacother"},{"key":"1425_CR27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/prca.201300010","volume":"7","author":"A Kuno","year":"2013","unstructured":"Kuno A, Sato T, Shimazaki H, et al. Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling. Proteom Clin Appl. 2013;7:642\u20137.","journal-title":"Proteom Clin Appl"},{"key":"1425_CR28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","volume":"3","author":"A Kuno","year":"2013","unstructured":"Kuno A, Ikehara Y, Tanaka Y, et al. A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065.","journal-title":"Sci Rep"},{"issue":"6","key":"1425_CR29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/14789450.2015.1084874","volume":"12","author":"H Narimatsu","year":"2015","unstructured":"Narimatsu H. Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis\/cirrhosis diagnostics. Expert Rev Proteom. 2015;12(6):683\u201393.","journal-title":"Expert Rev Proteom"},{"key":"1425_CR30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00535-014-0946-y","volume":"50","author":"T Toshima","year":"2015","unstructured":"Toshima T, Shirabe K, Ikegami T, et al. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol. 2015;50:76\u201384.","journal-title":"J Gastroenterol"},{"key":"1425_CR31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.27305","volume":"60","author":"K Yamasaki","year":"2014","unstructured":"Yamasaki K, Tateyama M, Abiru S, et al. Elevated serum levels of Wisteria floribunda agglutinin-positive Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 2014;60:1563\u201370.","journal-title":"Hepatology"},{"issue":"1","key":"1425_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12876-017-0618-5","volume":"17","author":"H Xu","year":"2017","unstructured":"Xu H, Kong W, Liu L, et al. Accuracy of M2BPGi, compared with Fibro Scan\u00ae, in analysis of liver fibrosis in patients with hepatitis C. BMC Gastroenterol. 2017;17(1):62. https:\/\/doi.org\/10.1186\/s12876-017-0618-5.","journal-title":"BMC Gastroenterol"},{"key":"1425_CR33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/liv.13188","volume":"37","author":"X Zou","year":"2017","unstructured":"Zou X, Zhu MY, Li W, et al. Serum WFA+-M2BP levels for evaluation of early stage of liver fibrosis in patients with chronic hepatitis B virus infection. Liver Int. 2017;37:35\u201344.","journal-title":"Liver Int"},{"issue":"35","key":"1425_CR34","doi-asserted-by":"crossref","first-page":"e4679","DOI":"10.1097\/MD.0000000000004679","volume":"95","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Hasegawa K, Ishii A, et al. A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation. Medicine. 2016;95(35):e4679.","journal-title":"Medicine"},{"key":"1425_CR35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/hepr.12703","volume":"47","author":"A Ishii","year":"2017","unstructured":"Ishii A, Nishikawa H, Enomoto H, et al. Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2 binding protein in treatment-na\u00efve chronic hepatitis B. Hepatol Res. 2017;47:204\u201315.","journal-title":"Hepatol Res"},{"key":"1425_CR36","doi-asserted-by":"publisher","first-page":"e177302","DOI":"10.1371\/journal.pone.0177302","volume":"12","author":"M Nakamura","year":"2017","unstructured":"Nakamura M, Kanda T, Jiang X, et al. Serum microRNA-122 and Wisteria floribunda agglutinin positive Mac-2-binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis. PLoS One. 2017;12:e177302. https:\/\/doi.org\/10.1371\/journal.pone.0177302.","journal-title":"PLoS One"},{"key":"1425_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22261","author":"B Wei","year":"2017","unstructured":"Wei B, Feng S, Chen E, Li D, et al. M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection. J Clin Lab Anal. 2017. https:\/\/doi.org\/10.1002\/jcla.22261 (Epub ahead of print).","journal-title":"J Clin Lab Anal"},{"issue":"8","key":"1425_CR38","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/hepr.12621","volume":"46","author":"E Miyaki","year":"2016","unstructured":"Miyaki E, Imamura M, Hiraga N, et al. Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients. Hepatol Res. 2016;46(8):758\u201364.","journal-title":"Hepatol Res"},{"issue":"1","key":"1425_CR39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4254\/wjh.v9.i1.64","volume":"9","author":"T Suda","year":"2017","unstructured":"Suda T, Okawa O, Masaoka R, et al. Shear wave elastography in hepatitis C patients before and after antiviral therapy. World J Hepatol. 2017;9(1):64\u20138.","journal-title":"World J Hepatol"},{"key":"1425_CR40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ajg.2015.118","volume":"110","author":"T Umemura","year":"2015","unstructured":"Umemura T, Joshita S, Sekiguchi T, et al. Serum Wisteria floribunda agglutinin positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis. Am J Gastroenterol. 2015;110:857\u201364.","journal-title":"Am J Gastroenterol"},{"key":"1425_CR41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/hepr.12595","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-\u03b3-inducible protein-10 in primary biliary cirrhosis. Hepatol Res. 2016;46:575\u201383.","journal-title":"Hepatol Res"},{"key":"1425_CR42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00535-016-1235-8","volume":"52","author":"N Yamada","year":"2017","unstructured":"Yamada N, Sanada Y, Tashiro M, et al. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia. J Gastroenterol. 2017;52:245\u201352.","journal-title":"J Gastroenterol"},{"key":"1425_CR43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/hepr.12596","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis. Hepatol Res. 2016;46:613\u201321.","journal-title":"Hepatol Res"},{"key":"1425_CR44","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00535-014-1007-2","volume":"50","author":"M Abe","year":"2015","unstructured":"Abe M, Miyake T, Kuno A, et al. Association between Wisteria floribunda agglutinin positive Mac-2-binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroetenrol. 2015;50:776\u201384.","journal-title":"J Gastroetenrol"},{"key":"1425_CR45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/hepr.12710","volume":"47","author":"M Mizuno","year":"2017","unstructured":"Mizuno M, Shima T, Oya H, et al. Classification of patients with non-alcoholic fatty liver disease using rapid immunoassay of serum type IV collagen compared with liver histology and other fibrosis markers. Hepatol Res. 2017;47:216\u201325.","journal-title":"Hepatol Res"},{"key":"1425_CR46","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/jims17091545","volume":"17","author":"R Shigefuku","year":"2016","unstructured":"Shigefuku R, Takahashi H, Nakano H, et al. Correlations of hepatic hemodynamics, liver function, and fibrosis markers in nonalcoholic fatty liver disease: comparison with chronic hepatitis related to hepatitis C virus. Int J Mol Sci. 2016;17:1545. https:\/\/doi.org\/10.3390\/jims17091545.","journal-title":"Int J Mol Sci"},{"key":"1425_CR47","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/hepr.12662","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis. Hepatol Res. 2016;46:1194\u2013202.","journal-title":"Hepatol Res"},{"key":"1425_CR48","first-page":"e174982","volume":"12","author":"LL Lai","year":"2017","unstructured":"Lai LL, Chan WK, Sthaneshwar P, et al. Serum Wisteria floribunda agglutinin positive Mac-2-binding protein in non-alcoholic fatty liver disease. PLoS One. 2017;12:e174982.","journal-title":"PLoS One"},{"key":"1425_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13802","author":"K Ito","year":"2017","unstructured":"Ito K, Murotani K, Nakade Y, et al. Serum WFA+-M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis. J Gastroenterol Hepatol. 2017. https:\/\/doi.org\/10.1111\/jgh.13802 (Epub ahead of print).","journal-title":"J Gastroenterol Hepatol"},{"key":"1425_CR50","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/jvh.12575","volume":"23","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Serum Wisteria floribunda agglutinin positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study. J Viral Hepat. 2016;23:977\u201384.","journal-title":"J Viral Hepat"},{"key":"1425_CR51","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DF Kleiner","year":"2005","unstructured":"Kleiner DF, Brunt EM, Natta MV, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"1425_CR52","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s12072-016-9754-1","volume":"10","author":"H Nagata","year":"2016","unstructured":"Nagata H, Nakagawa M, Nishimura-Sakurai Y, et al. Serum measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy. Hepatol Int. 2016;10:956\u201364.","journal-title":"Hepatol Int"},{"key":"1425_CR53","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/hepr.12473","volume":"45","author":"T Hanai","year":"2015","unstructured":"Hanai T, Shiraki M, Ohnishi S, et al. Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis. Hepatol Res. 2015;45:1083\u201390.","journal-title":"Hepatol Res"},{"key":"1425_CR54","first-page":"E47","volume":"47","author":"H Nishikawa","year":"2017","unstructured":"Nishikawa H, Takata R, Enomoto H, et al. Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-positive Mac-2 binding protein in chronic hepatitis C. Hepatol Res. 2017;47:E47\u201384.","journal-title":"Hepatol Res"},{"key":"1425_CR55","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/apt.13431","volume":"43","author":"K Ura","year":"2016","unstructured":"Ura K, Furusho N, Ogawa E, et al. Serum WFA(+)-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct acting anti-viral-based triple therapy for chronic hepatitis C. Aliment Phamacol Ther. 2016;43:114\u201324.","journal-title":"Aliment Phamacol Ther"},{"key":"1425_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24776","author":"T Watanabe","year":"2017","unstructured":"Watanabe T, Tokumoto Y, Joko K, et al. Predictors of treatment efficacy and ALT non-normalization with sofosbuvir\/ribavirin therapy for patients with hepatitis C virus genotype 2. J Med Virol. 2017. https:\/\/doi.org\/10.1002\/jmv.24776 (Epub ahead of print).","journal-title":"J Med Virol"},{"key":"1425_CR57","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/hepr.12655","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, et al. Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients. Hepatol Res. 2016;46:1065\u201373.","journal-title":"Hepatol Res"},{"key":"1425_CR58","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/ijms17091500","volume":"17","author":"K Hasegawa","year":"2016","unstructured":"Hasegawa K, Takata R, Nishikawa H, et al. Impact of Wisteria floribunda agglutinin positive Mac-2-binding protein in patients with hepatitis C virus related compensated liver cirrhosis. Int J Mol Sci. 2016;17:1500. https:\/\/doi.org\/10.3390\/ijms17091500.","journal-title":"Int J Mol Sci"},{"key":"1425_CR59","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/SLA.0000000000001836","volume":"265","author":"Y Okuda","year":"2017","unstructured":"Okuda Y, Taura K, Yoshino K, et al. Usefulness of Mac-2 binding protein glycosylation isomer for prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma. Ann Surg. 2017;265:1201\u20138.","journal-title":"Ann Surg"},{"key":"1425_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-017-1345-y","author":"K Morio","year":"2017","unstructured":"Morio K, Imamura M, Daijo K, et al. Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury. J Gastroenterol. 2017. https:\/\/doi.org\/10.1007\/s00535-017-1345-y.","journal-title":"J Gastroenterol"},{"key":"1425_CR61","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1111\/hepr.12466","volume":"45","author":"N Tamaki","year":"2015","unstructured":"Tamaki N, Kurosaki M, Kuno A, et al. Wisteria floribunda agglutinin positive Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients. Hepatol Res. 2015;45:E82\u20138.","journal-title":"Hepatol Res"},{"key":"1425_CR62","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.3390\/ijms17122143","volume":"17","author":"S Sato","year":"2016","unstructured":"Sato S, Genda T, Ichida T, et al. Prediction of hepatocellular carcinoma development after hepatitis C virus eradication using serum Wisteria floribunda agglutinin positive Mac-2-binding protein. Int J Mol Sci. 2016;17:2143. https:\/\/doi.org\/10.3390\/ijms17122143.","journal-title":"Int J Mol Sci"},{"key":"1425_CR63","first-page":"1134","volume":"50","author":"R Sasaki","year":"2015","unstructured":"Sasaki R, Yamasaki K, Abiru S, et al. Serum Wisteria floribunda agglutinin positive Mac-2-binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis C after sustained virological response. PLoS One. 2015;50:1134\u201344.","journal-title":"PLoS One"},{"key":"1425_CR64","doi-asserted-by":"crossref","first-page":"e3328","DOI":"10.1097\/MD.0000000000003328","volume":"95","author":"JY Heo","year":"2016","unstructured":"Heo JY, Kim SU, Kim BK, et al. Use of Wisteria floribunda agglutinin positive Mac-2-binding protein in assessing risk of hepatocellular carcinoma due to hepatitis B. Medicine. 2016;95:e3328.","journal-title":"Medicine"},{"key":"1425_CR65","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13341","author":"SU Kim","year":"2016","unstructured":"Kim SU, Heo JY, Kim BK, et al. Wisteria floribunda agglutinin positive Mac-2-binding protein predicts the risk of HBV-related liver cancer development. Liver Int. 2016. https:\/\/doi.org\/10.1111\/liv.13341 (Epub ahead of print).","journal-title":"Liver Int"},{"key":"1425_CR66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/hepr.12712","volume":"47","author":"Y Ichikawa","year":"2017","unstructured":"Ichikawa Y, Joshita S, Umemura T, et al. Serum Wisteria floribunda agglutinin positive Mac-2-binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Hepatol Res. 2017;47:226\u201333.","journal-title":"Hepatol Res"},{"key":"1425_CR67","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17670","author":"KS Cheung","year":"2017","unstructured":"Cheung KS, Seto WK, Wong DK, et al. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment. Oncotarget. 2017. https:\/\/doi.org\/10.18632\/oncotarget.17670 (Epub ahead of print).","journal-title":"Oncotarget"},{"key":"1425_CR68","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00535-010-0293-6","volume":"46","author":"M Tateyama","year":"2011","unstructured":"Tateyama M, Yatsuhashi H, Taura N, et al. Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol. 2011;46:92\u2013100.","journal-title":"J Gastroenterol"},{"key":"1425_CR69","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","volume":"61","author":"RH Westbrook","year":"2014","unstructured":"Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61:S58\u201368.","journal-title":"J Hepatol"},{"key":"1425_CR70","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00535-015-1063-2","volume":"50","author":"M Fujiyoshi","year":"2015","unstructured":"Fujiyoshi M, Kuno A, Gotoh M, et al. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma. J Gastroenterol. 2015;50:1134\u201344.","journal-title":"J Gastroenterol"},{"key":"1425_CR71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/liv.12907","volume":"36","author":"H Toyoda","year":"2016","unstructured":"Toyoda H, Kumada T, Tada T, et al. Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection. Liver Int. 2016;36:293\u2013301.","journal-title":"Liver Int"},{"key":"1425_CR72","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.rmed.2016.04.013","volume":"115","author":"M Kono","year":"2016","unstructured":"Kono M, Nakamura Y, Oyama Y, et al. Increased levels of serum Wisteria floribunda agglutinin positive Mac-2-binding protein in idiopathic pulmonary fibrosis. Respir Med. 2016;115:46\u201352.","journal-title":"Respir Med"},{"key":"1425_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12475","author":"T Fujiyama","year":"2017","unstructured":"Fujiyama T, Ito T, Ueda K, et al. Srume levels of Wisteria floribunda agglutinin positive Mac-2-binding protein reflect the severity of chronic pancreatitis. J Dig Dis. 2017. https:\/\/doi.org\/10.1111\/1751-2980.12475 (Epub ahead of print).","journal-title":"J Dig Dis"},{"key":"1425_CR74","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.pan.2016.09.003","volume":"16","author":"Y Waragai","year":"2016","unstructured":"Waragai Y, Suzuki R, Takagi T, et al. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein in pancreatic ductal adenocarcinoma. Pancreatology. 2016;16:1044\u201350.","journal-title":"Pancreatology"},{"key":"1425_CR75","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/j.gastro.2012.11.037","volume":"144","author":"MV Apte","year":"2013","unstructured":"Apte MV, Wilson JS, Lugaea A, et al. A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology. 2013;144:1210\u20139.","journal-title":"Gastroenterology"},{"key":"1425_CR76","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAIR Cooperative Study Group. Hepatology. 1996;24:289\u201393.","journal-title":"Hepatology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-017-1425-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T21:33:50Z","timestamp":1660253630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-017-1425-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1425"],"URL":"https:\/\/doi.org\/10.1007\/s00535-017-1425-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]}}}